ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A nanocomposite competent to overcome cascade drug resistance in ovarian cancer via mitochondria dysfunction and NO gas synergistic therapy

Zhong, Min; Liang, Peiqin; Feng, Zhenzhen; Yang, Xin; Li, Guang; Sun, Rui; He, Lijuan; Tan, Jinxiu; Xiao, Yangpengcheng; Yu, Zhiqiang*; Yi, Muhua*; Wang, Xuefeng*南方医科大学; 东莞市人民医院
Asian Journal of Pharmaceutical Sciences2023-11DOI: 10.1016/j.ajps.2023.100872
5阅读
引用收藏
分享

摘要

Ovarian cancer (OC) is one of the most common and recurring malignancies in gynecology. Patients with relapsed OC always develop "cascade drug resistance" (CDR) under repeated chemotherapy, leading to subsequent failure of chemotherapy. To overcome this challenge, amphiphiles (P1) carrying a nitric oxide (NO) donor (Isosorbide 5-mononitrate, ISMN) and high-density disulfide are synthesized for encapsulating mitochondria-targeted tetravalent platinum prodrug (TPt) to construct a nanocomposite (INP@TPt). Mechanism studies indicated that INP@TPt significantly inhibited drug-resistant cells by increasing cellular uptake and mitochondrial accumulation of platinum, depleting glutathione, and preventing apoptosis escape through generating highly toxic peroxynitrite anion (ONOO-). To better replicate the microenvironmental and histological characteristics of the drug resistant primary tumor, an OC patient-derived tumor xenograft (PDXOC) model in BALB/c nude mice was established. INP@TPt showed the best therapeutic effects in the PDXOC model. The corresponding tumor tissues contained high ONOO- levels, which were attributed to the simultaneous release of O2 center dot- and NO in tumor tissues. Taken together, INP@TPt-based systematic strategy showed considerable potential and satisfactory biocompatibility in overcoming platinum CDR, providing practical applications for ovarian therapy.

学科与关键词

关键词
Cisplatin resistancePatient-derived xenograft modelMitochondrial dysfunctionNitric oxideOvarian cancer
相关
加载中…
  • Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP
    Liu, Yuan; Wang, Yiru; Guan, Xue; Wu, Qiong; Zhang, Mengjun; Cui, Ping; Wang, Can; Chen, Xiuwei*; Meng, Xianwei*; Ma, Tengchuang*ACS applied materials & interfaces, 2023, 15(22): 26484-26495.被引 1
  • Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway
    Luo, Zhijian; Luo, Yantao; Liang, Xiaoling; Lyu, Qingyang; Meng, Fanliang; Chen, Xuncai; Wang, Yupeng; Fang, Weiyi*; Li, Aimin*; Zhou, Dongfang*ACS Biomaterials Science & Engineering, 2022, 8(6): 2526-2536.
  • A Cascade Targeted and Mitochondrion-Dysfunctional Nanomedicine Capable of Overcoming Drug Resistance in Hepatocellular Carcinoma
    Yang, Yuanyuan; Mai, Ziyi; Zhang, Yanxin; Yu, Zhiyu; Li, Wenjing; Zhang, Yuxuan; Li, Fangzhou; Timashev, Peter; Luan, Ping; Luo, Dixian*; Liang, Xing-Jie*; Yu, Zhiqiang*ACS Nano, 2023, 17(2): 1275-1286.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Asian Journal of Pharmaceutical Sciences
发表日期
2023-11
卷期
第 18 卷, 第 6 期
页码
100872
DOI
10.1016/j.ajps.2023.100872
期刊收录
CAST-E
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation of China [2021A1515011050]; President Foundation of The Third Affiliated Hospital of Southern Medical University [YM202202]

作者

  • Z

    Zhong, Min (第一作者)

    southern med univ

  • L

    Liang, Peiqin

    southern med univ

查看全部 12 位作者收起作者
  • F

    Feng, Zhenzhen

    new · southern med univ

  • Y

    Yang, Xin

    southern med univ

  • L

    Li, Guang

    southern med univ

  • S

    Sun, Rui

    dongguan peoples hosp · southern med univ

  • H

    He, Lijuan

    southern med univ

  • T

    Tan, Jinxiu

    southern med univ

  • X

    Xiao, Yangpengcheng

    southern med univ

  • Y

    Yu, Zhiqiang (通讯)

    new · southern med univ · dongguan peoples hosp

  • Y

    Yi, Muhua (通讯)

    southern med univ

  • W

    Wang, Xuefeng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417